2021 October - 19 articles
Interstitial lung diseases may have an unpredictably progressive course, which is manifested as progression of pulmonary fibrosis, causing an increasing impairment of lung function affecting a poor prognosis. The possibility of an effective antifibro...
Introduction: Pulmonary blastoma is a rare malignancy, accounting for less than 0.5% of primary lung tumors. It belongs to the group of pulmonary sarcomatoid carcinomas, and it is typically characterized by a biphasic pattern of an epithelial and a m...
A 43-year-old female presented with complaints of chest pain, non-productive cough, shortness of breath, diarrhoea, loss of weight and appetite, and generalised malaise for a period of one month [...]
Introduction: Increasing evidence has declared a hypercoagulable state in the coronavirus 2019 infection (COVID-19), while the etiology has remained a question. For the first time, the current study has aimed to compare the contributors of thromboemb...
Septic pulmonary embolism (SPE) is a serious complication of fulminant bacteraemia, usually seen in immunocompromised persons or intravenous drug abusers [...]
Hydatidosis, when present in multiple thoracic locations, requires a synchronous or successive approach, which can lead to an increased risk of complications [...]
The severe acute respiratory syndrome coro‑navirus 2 (SARS‑CoV‑2), causing coronavirus disease 2019 (COVID‑19), arrived in Belgium early February 2020 [...]
As healthcare systems in many countries buckle under the immense pressure of rising COVID cases, a drug which can reduce emergency visits would be a huge boon [...]
Ever since the results of the RECOVERY trial [...]
Introduction: COVID-19-associated pulmonary sequalae have been increasingly reported after recovery from acute infection. Therefore, we aim to explore the charactersitics of persistent lung parenchymal abnormalities in patients with COVID-19. Materia...
of 2
Get Alerted
Add your email address to receive forthcoming issues of this journal.
